Justice Department antitrust enforcers are preparing to approve CVS Health's (NYSE:CVS) planned acquisition of Aetna (NYSE:AET) and Cigna's (NYSE:CI) planned purchase of Express Scripts (NASDAQ:ESRX) within the next few weeks, WSJ reports.
The DoJ has identified some competition concerns in the CVS-AET deal and will require the companies to sell off assets related to Medicare drug coverage to resolve the concerns, according to the report; the size of the asset sales is not known, but one potential buyer in talks for the assets reportedly is WellCare Health Plans (NYSE:WCG).
DoJ approval of the CI-ESRX combination could come without the government requiring the companies to sell off any assets, the report says.
Now read: CVS Health: What Now? »
Subscribe for full text news in your inbox